Innospec Inc. reported a decrease in revenue by 9 percent to $435.0 million compared to the previous year. Net income increased to $31.2 million, with GAAP EPS at $1.24 and adjusted non-GAAP EPS at $1.39. The company's adjusted EBITDA was $54.1 million, and it maintains a debt-free balance sheet with over $240 million in net cash.
Performance Chemicals operating income more than doubled due to growth in personal care.
Fuel Specialties operating income increased double digits with margin expansion.
Oilfield Services results were negatively impacted by lower production chemical activity.
The company maintains a debt-free balance sheet with over $240 million in net cash.
Innospec anticipates maintaining improved results in the second half of 2024, with focus on technology-led growth opportunities. Oilfield Services expects lower sales levels to continue through the second half of 2024.
Visualization of income flow from segment revenue to net income